Form 4: OptimizeRx Corp Executive Stephen L. Silvestro Reports Stock and Option Grants

Stephen L. Silvestro, Chief Commercial Officer of OptimizeRx Corp, reports the acquisition of restricted stock units and stock options.

Summary

• Stephen L. Silvestro, the Chief Commercial Officer of OptimizeRx Corp, filed a Form 4 detailing changes in beneficial ownership.
• On May 15, 2025, Silvestro was granted 46,948 restricted stock units (RSUs) and options to purchase 80,884 shares of common stock.
• The RSUs vest in three equal annual installments starting May 15, 2026.
• The stock options, with an exercise price of $10.65, also vest in three equal annual installments beginning May 15, 2026, and expire on May 15, 2029.
• Following these transactions, Silvestro directly owns 168,262 shares of OptimizeRx common stock and 80,884 derivative securities.

Sentiment

Score: 7

Explanation: The document is a routine disclosure of executive compensation, which is generally neutral to slightly positive as it indicates investment in key personnel.

Positives

• The grant of RSUs and stock options to a key executive like the Chief Commercial Officer suggests an incentive alignment with the company's long-term performance.
• The vesting schedule encourages continued service and contribution from the executive.

Future Outlook

The vesting schedule of the RSUs and stock options indicates a multi-year incentive plan for the executive.

Industry Context

Stock option and RSU grants are common practices in the pharmaceutical technology industry to attract, retain, and incentivize key executives.

Comparison to Industry Standards

• Companies like Veeva Systems and GoodRx also utilize stock options and restricted stock units as part of their executive compensation packages.
• The vesting schedules and grant sizes are generally comparable to industry standards for similar executive roles in companies of comparable size and stage.

Stakeholder Impact

• Shareholders may view the grant of equity as an incentive for the executive to drive long-term value.
• Employees may see this as a positive sign of investment in leadership.

Key Dates

Keywords

OptimizeRx, Silvestro, Stock Options, Restricted Stock Units, Form 4, Beneficial Ownership, Executive Compensation